Invesco S&P MidCap 400 GARP ETF Rating $139.19 +0.33 (+0.24%) As of 10/12/2026 Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Invesco S&P MidCap 400 GARP ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.EWMC Aggregate RatingModerate Buy 2.56Holdings in EWMC have an aggregate rating of Moderate Buy based on 350 analyst ratings issued in the past year covering 25 companies (55.7% of the portfolio).EWMC Aggregate Price Target$139.19High Prediction$139.19Average Prediction$139.19Low Prediction$139.19Holdings in EWMC have an aggregate price target of $139.19 and a range of $139.19 to $139.19 covering 25 companies (55.7% of the portfolio).EWMC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P MidCap 400 GARP ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 EWMC Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.32%ANFAbercrombie & Fitch$151.40+3.8%Moderate Buy$155.38 2.6%153.049 of 5 stars2.99%DUOLDuolingo$140.10-5.2%Hold$125.31 -10.6%242.3706 of 5 starsTrending News2.98%HALOHalozyme Therapeutics$109.62-1.3%Moderate Buy$96.50 -12.0%123.2678 of 5 starsAnalyst Forecast2.77%IDCCInterDigital$332.88+1.4%Buy$450.00 35.2%43.7782 of 5 starsTrending NewsAnalyst Revision2.48%HLHecla Mining$16.17-4.0%Hold$23.34 44.4%104.2339 of 5 starsNews Coverage2.44%RNRRenaissanceRe$341.29+0.7%Hold$337.50 -1.1%183.9906 of 5 starsNews CoverageAnalyst ForecastAnalyst Revision2.41%PCTYPaylocity$158.11+1.3%Moderate Buy$163.76 3.6%172.0179 of 5 starsAnalyst Forecast2.40%SNSharkNinja$188.55-0.8%Buy$188.59 0.0%123.3611 of 5 starsNews Coverage2.36%APPFAppFolio$199.03+0.0%Moderate Buy$249.75 25.5%124.0366 of 5 stars2.33%MEDPMedpace$609.89-1.6%Hold$607.73 -0.4%132.6649 of 5 stars2.28%QLYSQualys$198.11+0.7%Hold$180.53 -8.9%172.4782 of 5 starsAnalyst Forecast2.25%KNSLKinsale Capital Group$340.56-0.2%Reduce$357.67 5.0%101.7265 of 5 starsAnalyst Forecast2.20%DOCUDocusign$72.31+1.9%Hold$67.33 -6.9%182.7698 of 5 stars2.16%THCTenet Healthcare$266.69-0.8%Moderate Buy$277.25 4.0%213.284 of 5 stars2.10%FTITechnipFMC$70.63+1.3%Moderate Buy$74.92 6.1%143.8636 of 5 starsAnalyst Forecast2.08%EXELExelixis$59.51-0.5%Hold$50.79 -14.7%202.3312 of 5 starsAnalyst Revision2.06%DOCSDoximity$30.49-0.3%Hold$31.95 4.8%253.805 of 5 starsTrending News2.04%LNTHLantheus$100.02-0.1%Hold$107.44 7.4%143.487 of 5 starsAnalyst Forecast1.82%MANHManhattan Associates$222.71+2.2%Moderate Buy$221.20 -0.7%101.822 of 5 starsNews CoverageAnalyst Upgrade1.78%GMEDGlobus Medical$76.210.0%Moderate Buy$99.46 30.5%174.2234 of 5 stars1.72%EXLSExlService$37.20+1.3%Moderate Buy$44.50 19.6%74.1288 of 5 stars1.71%RGAReinsurance Group of America$258.01-0.7%Moderate Buy$267.89 3.8%114.2906 of 5 starsPositive NewsAnalyst Forecast1.69%VALValaris$85.54+0.7%Reduce$67.80 -20.7%72.0378 of 5 stars1.68%SLMSLM$22.70-1.0%Hold$29.40 29.5%124.1885 of 5 starsNews CoverageAnalyst Forecast1.67%HLNEHamilton Lane$82.92-4.6%Moderate Buy$124.63 50.3%104.7016 of 5 starsAnalyst Forecast This page (NYSEARCA:EWMC) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P MidCap 400 GARP ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P MidCap 400 GARP ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
